BLUEBIRD BIO INC (BLUE) Stock Analyst Earnings Estimates
NASDAQ:BLUE - Nasdaq - US09609G1004 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.66M | 3.6M -1.64% | 29.497M 719.36% | 72.526M 145.88% | 246.51M 239.89% | 316.91M 28.56% | 369.5M 16.59% | 509.03M 37.76% | 626.28M 23.03% | 716.6M 14.42% | 799.27M 11.54% | 862.61M 7.92% | |
| EBITDA YoY % growth | -545.46M -1.03% | -379.15M 30.49% | -308.667M 18.59% | -253.292M 17.94% | -120.295M 52.51% | 14.28M 111.87% | 147.95M 936.06% | 284.9M 92.57% | 266.01M -6.63% | 253.87M -4.56% | N/A | N/A | |
| EBIT YoY % growth | -565.11M -1.05% | -384.15M 32.02% | -337.192M 12.22% | -302.236M 10.37% | -133.875M 55.71% | -180.288M -34.67% | -126.123M 30.04% | -35.547M 71.82% | 35.802M 200.72% | 108.78M 203.84% | 156.26M 43.65% | 187.48M 19.98% | |
| Operating Margin | -15,440.16% | -10,670.83% | -1,143.14% | -416.73% | -54.31% | -56.89% | -34.13% | -6.98% | 5.72% | 15.18% | 19.55% | 21.73% | |
| EPS YoY % growth | -11.80 -18.59% | -4.68 60.34% | N/A -652.93% | -27.77 21.19% | -8.82 68.23% | -14.48 -64.16% | -0.47 96.76% | -2.24 -378.26% | 2.75 222.73% | 7.75 181.48% | 10.91 40.79% | 13.06 19.63% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.30 52.25% | -0.19 47.78% | -0.13 69.64% | -0.02 93.42% | 0.01 102.28% |
| Revenue Q2Q % growth | 26.218M 234.67% | 35.292M 90.02% | 50.831M 215.70% | 71.479M 573.57% | 79.514M 203.28% |
| EBITDA Q2Q % growth | -65.193M -20.40% | -44.88M 29.01% | -40.188M 28.74% | -42.84M -155.47% | -43.86M 32.72% |
| EBIT Q2Q % growth | -63.697M 22.95% | -46.406M 41.03% | -33.606M 61.98% | -19.457M 69.65% | -7.984M 87.47% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.31 53.03% | -0.37 | 0.06 | 16.57% |
| Q2 2024 Q2Q % growth | -0.42 37.31% | -0.43 | 0.01 | 1.18% |
| Q1 2024 Q2Q % growth | -0.36 -271.43% | -0.45 | 0.09 | 19.91% |
| Q4 2023 Q2Q % growth | 22.93% | -0.62 | % | |
| Q3 2023 Q2Q % growth | -0.66 29.79% | -0.69 | 0.03 | 4.12% |
| Q2 2023 Q2Q % growth | -0.67 47.24% | -0.73 | 0.06 | 8.20% |
| Q1 2023 Q2Q % growth | 0.21 112.65% | -0.38 | 0.59 | 155.64% |
| Q4 2022 Q2Q % growth | -0.81 62.15% | -0.44 | -0.37 | -82.14% |
| Q3 2022 Q2Q % growth | -0.94 70.25% | -1.14 | 0.20 | 17.50% |
| Q2 2022 Q2Q % growth | -1.27 62.97% | -1.26 | -0.01 | -0.71% |
| Q1 2022 Q2Q % growth | -1.66 45.93% | -1.42 | -0.24 | -16.85% |
| Q4 2021 Q2Q % growth | -2.14 28.90% | -1.92 | -0.22 | -11.30% |
| Q3 2021 Q2Q % growth | -3.16 -7.48% | -2.64 | -0.52 | -19.64% |
| Q2 2021 Q2Q % growth | -3.43 -852.78% | -3.32 | -0.11 | -3.38% |
| Q1 2021 Q2Q % growth | -3.07 15.66% | -3.07 | 0.00 | -0.05% |
| Q4 2020 Q2Q % growth | -3.01 25.50% | -2.98 | -0.03 | -1.16% |
| Q3 2020 Q2Q % growth | -2.94 21.18% | -3.11 | 0.17 | 5.51% |
| Q2 2020 Q2Q % growth | -0.36 89.86% | -2.65 | 2.29 | 86.41% |
| Q1 2020 Q2Q % growth | -3.64 -21.74% | -4.09 | 0.45 | 11.03% |
| Q4 2019 Q2Q % growth | -4.04 | -3.86 | -0.18 | -4.58% |
| Q3 2019 Q2Q % growth | -3.73 | -3.59 | -0.14 | -3.93% |
| Q2 2019 Q2Q % growth | -3.55 | -3.13 | -0.42 | -13.59% |
| Q1 2019 Q2Q % growth | -2.99 | -2.85 | -0.14 | -4.80% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 10.612M -14.36% | 18.41M | -7.798M | -42.36% |
| Q2 2024 Q2Q % growth | 16.101M 133.69% | 24.739M | -8.638M | -34.92% |
| Q1 2024 Q2Q % growth | 18.573M 680.05% | 19.942M | -1.369M | -6.86% |
| Q4 2023 Q2Q % growth | 7.834M 7,734.00% | 9.854M | -2.02M | -20.50% |
| Q3 2023 Q2Q % growth | 12.392M 12,292.00% | 13.579M | -1.187M | -8.74% |
| Q2 2023 Q2Q % growth | 6.89M 359.33% | 12.177M | -5.287M | -43.42% |
| Q1 2023 Q2Q % growth | 2.381M 25.32% | 18.558M | -16.177M | -87.17% |
| Q4 2022 Q2Q % growth | 100K -93.75% | 13.805M | -13.705M | -99.28% |
| Q3 2022 Q2Q % growth | 100K -90.00% | 1.023M | -923K | -90.22% |
| Q2 2022 Q2Q % growth | 1.5M 1,400.00% | 694.243K | 805.757K | 116.06% |
| Q1 2022 Q2Q % growth | 1.9M 111.11% | 747.997K | 1.152M | 154.01% |
| Q4 2021 Q2Q % growth | 1.6M 100.67% | 5.185M | -3.585M | -69.14% |
| Q3 2021 Q2Q % growth | 1M -94.82% | 38.349M | -37.349M | -97.39% |
| Q2 2021 Q2Q % growth | 100K -99.95% | 18.309M | -18.209M | -99.45% |
| Q1 2021 Q2Q % growth | 900K -95.89% | 11.597M | -10.697M | -92.24% |
| Q4 2020 Q2Q % growth | -240M -591.64% | 14.946M | -254.946M | -1,705.78% |
| Q3 2020 Q2Q % growth | 19.3M 116.85% | 24.026M | -4.726M | -19.67% |
| Q2 2020 Q2Q % growth | 198.9M 1,395.49% | 68.032M | 130.868M | 192.36% |
| Q1 2020 Q2Q % growth | 21.9M 75.20% | 7.701M | 14.199M | 184.38% |
| Q4 2019 Q2Q % growth | -34.7M | 8.87M | -43.57M | -491.21% |
| Q3 2019 Q2Q % growth | 8.9M | 10.98M | -2.08M | -18.94% |
| Q2 2019 Q2Q % growth | 13.3M | 11.112M | 2.188M | 19.69% |
| Q1 2019 Q2Q % growth | 12.5M | 13.506M | -1.006M | -7.45% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 7.36% | 0% | -1814.92% |
| Revenue | 0% | -50.94% | -2.71% | -23.96% |